Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

Institute of Biomedical Research Corp. (MRES)

Compare
0.0142
+0.0005
+(3.65%)
At close: April 4 at 3:11:01 PM EDT
Loading Chart for MRES
  • Previous Close 0.0137
  • Open 0.0137
  • Bid 0.0131 x --
  • Ask 0.0142 x --
  • Day's Range 0.0137 - 0.0142
  • 52 Week Range 0.0001 - 0.0280
  • Volume 84,242
  • Avg. Volume 868,001
  • Market Cap (intraday) 34.066M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -6.4600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Its services include regulatory control of industrial activities and products; scientific surveillance of the living environment; research and development of biomedical products and technologies; regulatory evaluation and certification of biomedical products; fundamental scientific research; and development of new diagnostic methods and experimental medical treatments. The company also researchers and develops new biomedical and food products; provides programs for graduate research studies in biomedical and environmental fields; offers two channel analog NMS, digital muscle stimulator, digital TENS, interferential, elite combination, portable four channel digital, portable ultra sound, and other healthcare devices; and provides photon red light for beauty, electric pain relief products, microcurrent electrical nerve stimulators, and high volt pulsed stimulators. In addition, it develops and commercializes microbicidal agents; disinfectant products; bandages for large burns, hard surface disinfection, microbicidal treatment of fabrics and textile products, insecticides against bed bugs and other textile goods, microbicidal towels, and mouthwash products; Purilair, an appliance that sterilizes compressed air circulating within medical instruments; colloidal silver and electro medical devices; and BioStim INF that is used for edema reduction, pain relief, and total treatment. Further, the company provides quality control, regulatory, healthcare, environmental services, environmental analysis, building decontamination, and environmental protection and management services; and regulatory certifications of new biomedical products. Institute of Biomedical Research Corp. was founded in 2010 and is based in Podgorica, Montenegro with a representative office in Montreal, Canada.

mrescorp.com

--

Full Time Employees

--

Fiscal Year Ends

Recent News: MRES

View More

Performance Overview: MRES

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MRES
29.00%
S&P 500 (^GSPC)
13.73%

1-Year Return

MRES
37.86%
S&P 500 (^GSPC)
1.42%

3-Year Return

MRES
5.33%
S&P 500 (^GSPC)
10.72%

5-Year Return

MRES
7,000.00%
S&P 500 (^GSPC)
103.89%

Compare To: MRES

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MRES

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    34.07M

  • Enterprise Value

    34.07M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    -6.4600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: MRES

View More

Company Insights: MRES

Research Reports: MRES

View More

People Also Watch